<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240704062329N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-23</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>Effect of solution focused of spouse abuse</public_title>
      <acronym></acronym>
      <scientific_title>The effect of solution focused approach on the coping and resilience of women victims of spouse abuse</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77801</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Factorial, Purpose: Education/Guidance, Randomization description: In the current research, block randomization method is used (15 to 4 blocks), in each block, two allocations are considered for the intervention group and two allocations for the control group. Random sequence generation is done by the web method using the site (https://www.sealedenvelope.com) and by the respected professor of statistics.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Women victims of spouse abuse.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention of this research is short-term solution oriented counseling. After the pre-test, the members of the intervention group will benefit from short-term solution-oriented intervention in groups of 10, according to the Deshazer (1985) model, during 6 sessions of 90 minutes (one session per week). The members of the control group do not receive any intervention. Counseling sessions are conducted by students who have completed the relevant workshop and have an educational certificate, under the supervision of a project psychologist, in selected health centers in Arak city. Immediately after the end of the intervention (post-test), 4 weeks and 12 weeks after the end of the intervention (follow-up), adaptation and resilience questionnaires are completed for both groups by trained interviewers who are unaware of the placement of people in the intervention and control groups. Intervention 2: Control group: The members of the control group do not receive any intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the data related to the main outcome can be shared.

When:
The access period starts 6 months after the results are published.

To whom:
Researchers working in academic and scientific institutions

Conditions:
The use of documentation in educational and health centers

Where to obtain:
Hadiseh Arab
09183476506
arabhadise95940321189@gmail.com

How to obtain:
6 months after the results are printed, it takes time for these documents to be available to you.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hadiseh Arab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 2,Golha 6, Shahid Golmohammadi St, Imam Khomeini St.</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3816197175</zip>
        <telephone>+98 86 3277 3426</telephone>
        <email>arabhadise95940321189@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hadiseh Arab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 2, Golha6, Shahid Golmohammadi St, Imam Khomeini St.i</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3816197175</zip>
        <telephone>+98 86 3277 3426</telephone>
        <email>arabhadise95940321189@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18 to 39 years
Having at least one year of cohabitation with a spouse
Having experienced violence from the husband at least during the last year (getting at least one score from the subscales of physical assault, psychological aggression, negotiation, sexual coercion and injury of the aggressive form of the CTS2 questionnaire)
Obtaining a resilience score of &lt;50 from the Connor and Davidson questionnaire
Ability to understand and speak Persian
Having at least a third middle school degree
Having Iranian nationality
Having a permanent marriage and being married at the moment
Absence during pregnancy and postpartum period (up to 6 months after delivery)
Failure to simultaneously participate in counseling courses with the same content as the present intervention
Not experiencing any severe stressors such as divorce, accident and bereavement of relatives in the last 6 months</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>39 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Taking psychotropic drugs including anti-anxiety drugs (such as clonazepam, alprozolam, lorazepam), antidepressants (such as fluoxetine, paroxetine, sertraline), antipsychotic drugs (such as chlorpromazine, fluphenazine, haloperidol), mood stabilizers (such as lithium, carbamazepine, sodium valproate) ) and stimulants (such as amphetamine, dexmethylphenidate, dextroamphetamine) within 6 months before participating in the study and during the study
Having a history of hospitalization in the neurology department
Having any underlying and incurable diseases such as cancer or malignant tumors
Abuse of alcohol and drugs in yourself or your spouse
Having impaired consciousness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention of this research is short-term solution oriented counseling. After the pre-test, the members of the intervention group will benefit from short-term solution-oriented intervention in groups of 10, according to the Deshazer (1985) model, during 6 sessions of 90 minutes (one session per week). The members of the control group do not receive any intervention. Counseling sessions are conducted by students who have completed the relevant workshop and have an educational certificate, under the supervision of a project psychologist, in selected health centers in Arak city. Immediately after the end of the intervention (post-test), 4 weeks and 12 weeks after the end of the intervention (follow-up), adaptation and resilience questionnaires are completed for both groups by trained interviewers who are unaware of the placement of people in the intervention and control groups.</i_keyword>
      <i_keyword>Control group: The members of the control group do not receive any intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Coping score in the coping inventory for intimate partner violence. Timepoint: Measurement time, before the start of the intervention (pre-test), immediately after the end of the intervention (post-test), 4 weeks and 12 weeks after the last session of the intervention (follow-up). Method of measurement: Coping is measured with Coping Inventory for Intimate Partner Violence (CIIPV)uestionnaire designed by Taherkhani (2022).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Resilience score in the questionnaire Connor-Davidson Resilience Scale. Timepoint: The measurement time is before the start of the intervention (pre-test), immediately after the end of the intervention (post-test), 4 weeks and 12 weeks after the last session of the intervention (follow-up). Method of measurement: Resilience is measured by Conner and Davidson's (2003)Connor-Davidson Resilience Scale (CD-RISC).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-02-20</approval_date>
        <contact_name>Ethics committee of Arak University of Medical Sciences</contact_name>
        <contact_address>No.2, Golha6, Shahid Golmohammadi St, Emam Khomeini St. Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
